Anhil Pharmaceuticals Llp - Company Profile

It is a chemicals and materials limited liability partnership based in Mumbai, Maharashtra, India, established in 2014.
2014 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Anhil Pharmaceuticals Llp

Anhil Pharmaceuticals Llp, a active limited liability partnership, was established on 10 November 2014 in Mumbai, Maharashtra, India. Engaging in industrial chemicals within the chemicals and materials sector, it holds LLPIN: AAC-8940. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Deepak Revantilal Shah (Designated Partner), Pragna Deepak Shah (Designated Partner). Past directors included Vishal Deepak Shah, Darshan Deepak Shah. Its latest date of accounts and solvency statement 31 March 2025. It is based at 22, Duru Mahal, 5Th Floor, 84, Marine Drive, F Road, Mumbai, Mumbai, Maharashtra, 400002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAC-8940

  • Incorporation Date

    10 November 2014

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 11 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Anhil Pharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Anhil Pharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Anhil Pharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Deepak Revantilal Shah Designated Partner 10 Nov 2014 Current
Pragna Deepak Shah Designated Partner 10 Nov 2014 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner - Past
Pramod Abcsdd Partner - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anhil Pharmaceuticals Llp.

Enhance accessibility to Anhil Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Anhil Pharmaceuticals Llp revenue growth over time
Anhil Pharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anhil Pharmaceuticals Llp?

Unlock access to Anhil Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Anhil Pharmaceuticals Llp?

Unlock and access historical data on people associated with Anhil Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Anhil Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anhil Pharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anhil Pharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Anhil Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Progress on Anhil Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Deepak Revantilal Shah was appointed as a Designated Partner was appointed as a Designated Partner on 10 Nov 2014 & has been associated with this company since 11 years 2 months . was completed.

  • Director Appointment

    Progress on Pragna Deepak Shah was appointed as a Designated Partner was appointed as a Designated Partner on 10 Nov 2014 & has been associated with this company since 11 years 2 months . was documented.

  • LLP Incorporation

    Progress on Anhil Pharmaceuticals Llp was registered on 10 Nov 2014 with Roc Mumbai & aged 11 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Anhil Pharmaceuticals Llp?

The LLPIN of Anhil Pharmaceuticals Llp is AAC-8940.

Where is Anhil Pharmaceuticals Llp headquartered?

Anhil Pharmaceuticals Llp is headquartered at 22, Duru Mahal, 5Th Floor, 84, Marine Drive, F Road, Mumbai, Mumbai, Maharashtra, 400002.

When was Anhil Pharmaceuticals Llp incorporated?

Anhil Pharmaceuticals Llp was incorporated on 10 November 2014.

Who are the current directors of Anhil Pharmaceuticals Llp?

The current directors of Anhil Pharmaceuticals Llp are

What is the primary industry of Anhil Pharmaceuticals Llp?

The primary industry of Anhil Pharmaceuticals Llp is Chemicals And Materials.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available